Nautic Partners, LLC (“Nautic”) and Ferrer Freeman & Company, LLC (“FFC”) announced the sale of Asheville, NC-based Genova Diagnostics, Inc. (“Genova” or the “Company”) to Levine Leichtman Capital Partners (“LLCP”) and members of Genova management. Genova, founded in 1986, is a global specialty clinical laboratory that has pioneered a unique, systems-based approach to testing that supports the personalized treatment and prevention of chronic disease. The Company offers more than 125 specialized diagnostic assessments that cover digestive, metabolic, immunology, endocrinology and other physiological areas. It currently serves more than 10,000 primary care physicians, specialists and other healthcare providers.
Ted Hull, Chairman and CEO of Genova said, “On behalf of the Company, I’d like to thank Nautic and FFC for their partnership in building the Company to where it is today. We operated as partners and succeeded together. We believe the Company is well positioned to continue on its growth trajectory into the future under LLCP’s ownership.”
Chris Crosby, Managing Director at Nautic said, “We want to thank the management team and employees of Genova for all of their hard work and effort to make Genova a great company, one that serves physicians and their patients in the quest to identify and treat chronic disease.”
Ted Lundberg, Partner at FFC added, “The partnership with Genova’s management team has been unique and rewarding. We wish the Company and its new financial partner success in this exciting next phase of growth.”
Genova was advised by Lazard Middle Market. Goodwin Procter served as legal advisor to Genova.
About Ferrer Freeman & Company, LLC
Ferrer Freeman & Company, LLC is a private equity firm located in Greenwich, CT focused on making growth capital investments in healthcare companies. Since its founding in 1995, FFC has invested over $900 million in 36 portfolio companies. FFC invests in established companies in the middle market with significant growth opportunities, backs proven management teams, and then leverages its comprehensive healthcare network and value creation model to accelerate growth and build market leading and strategically valuable companies. For more information, please visit www.ffandco.com.
